Dermal Cell News 6.05 February 10, 2020 | |
| |
TOP STORYIn vitro and in vivo functional experiments were performed to determine the effect of ATP-citrate lyase (ACLY) on melanoma growth. mRNA expression profile analysis and a panel of biochemical assays were used to investigate the role of ACLY in mitochondrial oxidative phosphorylation. [Clin Cancer Res] Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)DERMAL STEM CELLS & TISSUE REGENERATIONIn porcine pre-clinical models of full-thickness burn, scientists delivered mesenchymal stem/stromal cell-containing fibrin sheets directly to the wound bed, improving re-epithelialization, dermal cell repopulation, and neovascularization. [Biofabrication] Abstract Researchers analyzed the bioactivity of tryptanthrin under infectious conditions using an in vitro dermatophytosis model employing fibroblasts and keratinocytes infected with T. benhamiae DSM6916. [Sci Rep] Full Article The cell viability and the cytotoxicity of a developed copolymer were evaluated by using human dermal fibroblast cells. The addition of silver nitrate within the polymer matrix resulted in a significant decrease in the adhesion of different types of microorganisms on the scaffold. [Biomed Mater] Abstract The role of acetylated histone H3K18 (H3K18 ac) in arsenic-induced DNA damage, HaCaT cells were exposed to sodium arsenite for 24 hours. It was found that arsenic induced the downregulation of xeroderma pigmentosum A, D, and F expression, as well as histone H3K18 ac expression, and aggravated DNA damage. [Hum Exp Toxicol] Abstract SKIN CANCERS & DISORDERSCirculating Tumor Cell Detection and Polyomavirus Status in Merkel Cell Carcinoma Investigators compared circulating tumors cell (CTC) detection and characterization in blood samples of patients with Merkel cell carcinoma using the CellSearch System and the RosetteSep -DEPArray workflow, an innovative procedure to enrich, detect and isolate single CTCs. [Sci Rep] Full Article The authors found that gypenoside LI had a potent cytotoxic effect on melanoma cells. Gypenoside LI induced intrinsic apoptosis along with S phase arrest. Furthermore, gypenoside LI inhibited the colony formation ability of melanoma through inhibition of the Wnt/β-catenin signaling pathway. [J Biochem Mol Toxicol] Abstract Scientists evaluated the effect of conditioned medium obtained from the supernatant of activated and non-activated Jukart-E6 cells, as well as from one murine and one human melanoma cell line. [Cell Biol Int] Abstract To correlate in vivo results with in vitro cytotoxicity, B16-F0 cells were cultured to determine: cell proliferation and viability by dye exclusion assays, MTT and CFSE dilution. [Heliyon] Abstract Subscribe to one of our other 19 science newsletters such as Extracellular Matrix News & Cancer Stem Cell News. | |
| |
REVIEWSDo Innate Killing Mechanisms Activated by Inflammasomes Have a Role in Treating Melanoma? Some of the innate mechanisms that have evolved against infections with microorganisms and viruses are proving to be active against cancer cells but require better understanding of how they are activated and what inhibitory mechanisms may need to be targeted. [Pigment Cell Melanoma Res] Abstract Visit our reviews page to see a complete list of reviews in the dermal cell research field. | |
| |
INDUSTRY NEWSAbbVie announced positive top-line results from the Phase III SELECT-PsA 1 clinical trial. In this study, both doses of upadacitinib met the primary endpoint of ACR20 response at week 12 versus placebo in adult patients with active psoriatic arthritis. [AbbVie, Inc.] Press Release UArizona Cancer Center Receives $6.9M Grant to Study Targeted Prevention of Non-Melanoma Skin Cancer With funding from the National Cancer Institute, a team of researchers at the University of Arizona Cancer Center is seeking effective preventive and therapeutic strategies to reduce the risk of non-melanoma skin cancer, like squamous cell carcinoma of the skin. [University of Arizona] Press Release | |
| |
POLICY NEWSTrump’s 2021 Budget Drowns Science Agencies in Red Ink, Again It’s another sea of red ink for federal research funding programs in President Donald Trump’s latest budget proposal. The 2021 budget request to Congress released February 10th calls for deep, often double-digit cuts to R&D spending at major science agencies. [ScienceInsider] Editorial Major Cancer Institute Sued by Its Own Researchers Over ‘Tapering’ Funding Alleging that a leading cancer funder is slashing their support in an “unethical and reckless” way, six prominent cancer researchers at the University of California, San Diego have filed a lawsuit to compel it to continue its current level of support. [ScienceInsider] Editorial
| |
EVENTSNEW American Association for Cancer Research (AACR) Annual Meeting 2020 Visit our events page to see a complete list of events in the community.
| |
JOB OPPORTUNITIESNEW Senior Research Scientist – Sarcoma (Memorial Sloan Kettering Cancer Center) Postdoctoral Position – Cancer Biology (Kentsis Research Group) Researcher – Dermatopathology (Weill Cornell Medical College) Postdoctoral Fellow – Cancer Pathogenesis (University of Cincinnati) Postdoctoral Position – Tissue Repair and Inflammation (Memorial Sloan Kettering Cancer Center) Postdoctoral Fellow – Cancer Research (University of California, San Diego) Postdoctoral Fellowship – DNA Repair in Skin Melanoma Prevention (University of Southern California) Postdoctoral Position – Microbiota and Autoimmunity (The University of Arizona) Chief Position – Allergy, Immunology, Rheumatology and Dermatology (Harvard Medical School) Senior Associate Researcher – Inflammatory Skin Diseases (Icahn School of Medicine at Mount Sinai) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Dermal Cell News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|